Sodicta, Meriam .

HRN: 15-36-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
METRONIDAZOLE 500MG (TAB)
05/04/2026
05/11/2026
PO
500 Mg
TID
LTCS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: